GENELUX Corp
WESTLAKE VILLAGE, CA · CIK 0001231457 · Biotech · Public
Oncolytic virus immunotherapy platform
genelux.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $24M
- 5 Form D · Jun 2023
- 39 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓200820102012201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $48,000 | |
| Private capital raised | Form D · SEC | $80,000 | |
| Private capital raised | Form D · SEC | $481,268 | |
| Private capital raised | Form D · SEC | $18,304,319 | |
| Private capital raised | Form D · SEC | $5,500,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1571 | Macromoltek | — | — |
| 1572 | Coultreon Biopharma | — | — |
| 1573 | NANORED LLC | — | — |
| 1574 | GENELUX Corp | — | $24M |
| 1575 | RUMI SCIENTIFIC, INC. | — | — |
| 1576 | Max Biopharma, Inc. | — | — |
| 1577 | Neurocarrus Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- DENNIS FENTONDirector
- Joachim-Friedrich KappDirector
- CATHERINE MACKEYDirector
- Mary MirabelliDirector
- Kevin MurphyExecutive Officer
- Albert RoderDirector · Executive Officer
- ALBERT RODERDirector · Executive Officer
- Albert RoederDirector · Executive Officer
- Doug SamuelsonExecutive Officer
- Paul ScigallaExecutive Officer
- Ronald SimusDirector · Executive Officer
- RONALD SIMUSDirector · Executive Officer
- Caroline StaibExecutive Officer
- Aladar SzalayDirector · Executive Officer
- ALADAR SZALAYDirector · Executive Officer
- John ThomasDirector
- JOHN THOMASDirector
- James TyreeDirector
- JAMES TYREEDirector
- Gabe WoodwardDirector
- Thomas ZindrickDirector · Executive Officer
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.